|
🐜
|
Lenalidomide after stem-cell transplantation for multiple myeloma.
40 auth.
P. McCarthy,
K. Owzar,
C. Hofmeister,
D. Hurd,
H. Hassoun,
P. Richardson,
S. Giralt,
E. Stadtmauer,
D. Weisdorf,
R. Vij,
J. Moreb,
N. Callander,
K. van Besien,
T. Gentile,
L. Isola,
...
R. Maziarz,
D. Gabriel,
A. Bashey,
H. Landau,
T. Martin,
M. Qazilbash,
D. Levitan,
B. Mcclune,
R. Schlossman,
V. Hárs,
John Postiglione,
Chen Jiang,
E. Bennett,
S. Barry,
L. Bressler,
M. Kelly,
Michele Seiler,
C. Rosenbaum,
P. Hari,
M. Pasquini,
M. Horowitz,
T. Shea,
S. Devine,
K. Anderson,
C. Linker
|
10 |
2012 |
10
🐜
|
|
🐜
|
A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma.
23 auth.
D. Siegel,
T. Martin,
Michael L. Wang,
R. Vij,
A. Jakubowiak,
S. Lonial,
S. Trudel,
V. Kukreti,
N. Bahlis,
M. Alsina,
...
A. Chanan-Khan,
F. Buadi,
F. Reu,
G. Somlo,
J. Zonder,
K. Song,
A. Stewart,
E. Stadtmauer,
L. Kunkel,
Sandra Wear,
A. Wong,
R. Orlowski,
S. Jagannath
|
9 |
2012 |
9
🐜
|
|
🐜
|
Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies
11 auth.
D. Siegel,
T. Martin,
A. Nooka,
R. Harvey,
R. Vij,
R. Niesvizky,
...
A. Badros,
S. Jagannath,
L. Mcculloch,
K. Rajangam,
S. Lonial
|
8 |
2013 |
8
🐜
|
|
🐢
|
Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline.
21 auth.
J. Mikhael,
Nofisat Ismaila,
M. Cheung,
C. Costello,
M. Dhodapkar,
Shaji K. Kumar,
M. Lacy,
B. Lipe,
R. Little,
A. Nikonova,
...
J. Omel,
Namrata Peswani,
A. Prica,
N. Raje,
R. Seth,
D. Vesole,
I. Walker,
A. Whitley,
T. Wildes,
S. Wong,
T. Martin
|
7 |
2019 |
7
🐢
|
|
🐜
|
Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years.
15 auth.
R. Wong,
S. Giralt,
T. Martin,
D. Couriel,
A. Anagnostopoulos,
C. Hosing,
B. Andersson,
P. Cano,
Munir Shahjahan,
C. Ippoliti,
...
E. Estey,
J. Mcmannis,
J. Gajewski,
R. Champlin,
M. de Lima
|
7 |
2003 |
7
🐜
|
|
🐜
|
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group.
70 auth.
P. Moreau,
Shaji K. Kumar,
J. S. San Miguel,
F. Davies,
E. Zamagni,
N. Bahlis,
H. Ludwig,
J. Mikhael,
E. Terpos,
F. Schjesvold,
T. Martin,
K. Yong,
B. Durie,
T. Facon,
A. Jurczyszyn,
...
S. Sidana,
N. Raje,
N. V. D. van de Donk,
S. Lonial,
M. Cavo,
S. Kristinsson,
S. Lentzsch,
R. Hájek,
K. Anderson,
C. João,
H. Einsele,
P. Sonneveld,
M. Engelhardt,
R. Fonseca,
A. Vangsted,
K. Weisel,
R. Baz,
V. Hungria,
J. Berdeja,
F. Leal da Costa,
Â. Maiolino,
A. Waage,
D. Vesole,
E. Ocio,
H. Quach,
C. Driessen,
J. Bladé,
X. Leleu,
E. Riva,
P. Bergsagel,
J. Hou,
W. Chng,
U. Mellqvist,
D. Dytfeld,
J. Harousseau,
H. Goldschmidt,
J. Laubach,
N. Munshi,
F. Gay,
M. Beksaç,
L. Costa,
M. Kaiser,
P. Hari,
M. Boccadoro,
S. Usmani,
S. Zweegman,
S. Holstein,
O. Sezer,
S. Harrison,
H. Nahi,
G. Cook,
M. Mateos,
S. Rajkumar,
M. Dimopoulos,
P. Richardson
|
7 |
2021 |
7
🐜
|
|
🦁
|
A phase 1b study of isatuximab plus lenalidomide and dexamethasone for relapsed/refractory multiple myeloma.
11 auth.
T. Martin,
R. Baz,
D. Benson,
N. Lendvai,
J. Wolf,
P. Munster,
...
A. Lesokhin,
C. Wack,
Eric Charpentier,
F. Campana,
R. Vij
|
7 |
2017 |
7
🦁
|
|
🐜
|
Carfilzomib in multiple myeloma patients with renal impairment: pharmacokinetics and safety
9 auth.
A. Badros,
R. Vij,
T. Martin,
J. Zonder,
L. Kunkel,
Zhengping Wang,
...
Susan Lee,
A. Wong,
R. Niesvizky
|
7 |
2013 |
7
🐜
|
|
🐜
|
Randomized multicenter phase 2 study of pomalidomide, cyclophosphamide, and dexamethasone in relapsed refractory myeloma.
14 auth.
R. Baz,
T. Martin,
Hui-Yi Lin,
Xiuhua Zhao,
K. Shain,
H. Cho,
J. Wolf,
A. Mahindra,
A. Chari,
D. Sullivan,
...
L. Nardelli,
K. Lau,
M. Alsina,
S. Jagannath
|
7 |
2016 |
7
🐜
|
|
🐜
|
Phase 2 dose-expansion study (PX-171-006) of carfilzomib, lenalidomide, and low-dose dexamethasone in relapsed or progressive multiple myeloma.
9 auth.
Michael L. Wang,
T. Martin,
W. Bensinger,
M. Alsina,
D. Siegel,
E. Kavalerchik,
...
Mei Huang,
R. Orlowski,
R. Niesvizky
|
7 |
2013 |
7
🐜
|
|
🐜
|
NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018.
30 auth.
Shaji K. Kumar,
Natalie S. Callander,
M. Alsina,
D. Atanackovic,
J. S. Biermann,
J. Castillo,
Jason C. Chandler,
C. Costello,
M. Faiman,
Henry C. Fung,
Kelly Godby,
C. Hofmeister,
L. Holmberg,
S. Holstein,
Carol Ann Huff,
...
Yubin Kang,
A. Kassim,
M. Liedtke,
E. Malek,
T. Martin,
V. Neppalli,
J. Omel,
N. Raje,
S. Singhal,
G. Somlo,
K. Stockerl-Goldstein,
D. Weber,
J. Yahalom,
Rashmi Kumar,
Dorothy Shead
|
7 |
2018 |
7
🐜
|
